Yao et al. [80] found that the performance of exosomal THEMIS2-211 is superior to AFP in the diagnosis of stage I HCC patients (with an AUC of 0.818 compared to 0.731) and its upregulated level was associated with the poor prognosis of HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.